With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients||Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD||Young Investigator Grants||2014||Massachusetts|
|Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer||Baylor College of Medicine / Stephen Gottschalk, M.D.||Innovation Grants||2014||Texas|
|Trk-Targeted Therapy of Human Neuroblastomas||Children's Hospital of Philadelphia / Garrett Brodeur, M.D.||Bridge Grants||2014||Pennsylvania|
|Trib2 in the Pathogenesis of T-ALL||University of Pennsylvania / Warren Pear, M.D., Ph.D.,||Innovation Grants||2014||Pennsylvania|
|Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy||Dana-Farber Cancer Institute / Yana Pikman, MD||Young Investigator Grants||2014||Massachusetts|
|Therapies for SHH-subtype Medulloblastoma||Dana-Farber Cancer Institute / Rosalind Segal, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|
|The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2014||Pennsylvania|
|The Role of MST1 in Non-canonical Hippo Signaling in Rhabdomyosarcoma||Duke University / Lisa Crose, Ph.D.||'A' Award Grants||2014||North Carolina|
|Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, M.D.||Innovation Grants||2014||Maryland|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|